Medications

New ALS drug approved in Canada while still under FDA review

An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness.

Vaccination

Vaccine maker recounts 'breakfast table' pivot to COVID work

The doctor who led development of the first COVID-19 vaccine authorized in the United States, Britain and elsewhere said her company's decision to shift from cancer research to battling the coronavirus happened over breakfast ...

Health

How safe is it to fly?

(HealthDay)—Buckle up and get ready for take-off: Flying has never been safer, an expert says.